title: Oral lesions in the course of myelofibrosis successfully treated using combination therapy with thalidomide, betamethasone, and cytarabine.
authors: Hematology Center Karolinska, Karolinska University Hospital Huddinge, Stockholm, Sweden. maciej.machaczka@ki.se
authors: Maciej
authors: M
authors: Machaczka
authors: Christer
authors: C
authors: Laurizohn
mesh_terms: D000368:Aged; D001623:Betamethasone / Q000008:administration & dosage*; D002176:Candida albicans / Q000302:isolation & purification; D003561:Cytarabine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D019226:Oral Ulcer / Q000188:drug therapy* / Q000382:microbiology*; D055728:Primary Myelofibrosis / Q000150:complications*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013792:Thalidomide / Q000008:administration & dosage*
chemical_list: D003561:Cytarabine; D013792:Thalidomide; D001623:Betamethasone